True B L, Alexander B, Carter B
Drug Intell Clin Pharm. 1985 Nov;19(11):825-7. doi: 10.1177/106002808501901105.
Substituting one monoamine oxidase inhibitor for another is recommended only after a drug-free interval to avoid hypertensive emergencies. The evidence and mechanism firmly supporting this caution is lacking. We report a case where monoamine oxidase inhibitors were substituted without apparent adverse consequences.
仅在经过无药间隔期后才建议将一种单胺氧化酶抑制剂替换为另一种，以避免高血压急症。但缺乏确凿支持这一谨慎做法的证据和机制。我们报告了一例替换单胺氧化酶抑制剂但未出现明显不良后果的病例。
